Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium
Authors:
Open Access
- 4 November 2019
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 10 (1) , 1-16
Abstract
Background: Serum-free xenogen-free defined media and continuous controlled physiological cell culture conditions have been developed for stem cell therapeutics, but the effect of these conditions on the relative potency of the cell product is unknown. As such, we conducted a head-to-head comparison of cell culture conditions on human heart explant-derived cells using established in vitro measures of cell potency and in vivo functional repair. Methods: Heart explant-derived cells cultured from human atrial or ventricular biopsies within a serum-free xenogen-free media and a continuous physiological culture environment were compared to cells cultured under traditional (high serum) cell culture conditions in a standard clean room facility. Results: Transitioning from traditional high serum cell culture conditions to serum-free xenogen-free conditions had no effect on cell culture yields but provided a smaller, more homogenous, cell product with only minor antigenic changes. Culture within continuous physiologic conditions markedly boosted cell proliferation while increasing the expression of stem cell-related antigens and ability of cells to stimulate angiogenesis. Intramyocardial injection of physiologic cultured cells into immunodeficient mice 1 week after coronary ligation translated into improved cardiac function and reduced scar burden which was attributable to increased production of pro-healing cytokines, extracellular vesicles, and microRNAs. Conclusions: Continuous physiological cell culture increased cell growth, paracrine output, and treatment outcomes to provide the greatest functional benefit after experimental myocardial infarction.Keywords
Funding Information
- Canadian Institutes of Health Research (PJT-162088, MC2-121291)
- Canadian Institutes of Health Research (Frederick Banting and Charles Best Canada Graduate Scholarship)
- Stem Cell Network (NA)
This publication has 57 references indexed in Scilit:
- Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarctionNature Communications, 2019
- Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem CellsTheranostics, 2017
- MSC-Based Product Characterization for Clinical Trials: An FDA PerspectiveCell Stem Cell, 2014
- Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repairCardiovascular Research, 2010
- Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial TissuePLOS ONE, 2009
- The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trialEuropean Heart Journal, 2008
- Human cardiac stem cellsProceedings of the National Academy of Sciences, 2007
- The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cellsNature Clinical Practice Cardiovascular Medicine, 2007
- Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic studyJACC, 2002
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996